Loading data for CORT — first visit, this takes a few seconds.

アラート

Corcept Therapeutics (CORT)

NasdaqCM: CORT · リアルタイム株価 · USD

118.10

+0.93 (0.79%)

終値時点： Aug 19, 2026, 1:47 PM

0.79% (1D)

データがありません

買気配	109.92
時価総額	13.03B
売上高（TTM）	830.81M
純利益（TTM）	54.27M
ベータ	0.46
EPS（TTM）	0.45
PER（TTM）	267.78
予想PER	27.37
PBR（TTM）	18.43
PSR（TTM）	15.68
Earnings Date	Nov 4, 2026

売気配	116.64
出来高	776,197
平均出来高（20日）	1,108,004
始値	116.59
前日終値	117.17
当日レンジ	116.59 - 119.95
52週レンジ	28.66 - 122.21
アナリスト	n/a
目標株価	n/a
配当	n/a
権利落ち日	n/a

CORTについて

Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have...

[続きを読む]

業種 Biotechnology

セクター Healthcare

IPO日 Apr 14, 2004

従業員数 730

上場取引所 NasdaqCM

ティッカー CORT

ウェブサイト https://www.corcept.com

企業情報の全文

業績

2025年のCorcept Therapeuticsの売上高は761.41Mで、前年の675.04Mから12.79%の増加でした。利益は99.65Mで、-29.43%の減少でした。

財務諸表

決算サプライズ

Corcept TherapeuticsはJul 29, 2026に四半期決算を発表しました：

売上高は $256.15M で、予想を下回りました $0, うち 31.74% の前年比増加にあたります.

EPSは 0.36 で、予想を上回りました 0.30, うち 24.14% の前年比増加にあたります.

次回決算発表

Corcept Therapeuticsの決算発表予定日は Nov 4, 2026, 取引時間中の予定です。
アナリストの売上高予想は ... アップグレード

ニュース

3日前 · StockStory

1 Surging Stock to Own for Decades and 2 We Brush Off

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or ...

1週間前 · Simply Wall St.

Corcept Therapeutics (CORT) Stock May Trade At A Discount Yet A Premium On Sales

Corcept Therapeutics stock has delivered a very strong run over the past few years, yet its low overall value score suggests the current share price may already reflect a lot of optimism. After such a...

1週間前 · Barchart

Corcept Therapeutics Stock Shines at New All-Time Highs Despite Its Valuation

Corcept Therapeutics (CORT) demonstrates exceptional price momentum with shares up more than 50% over the past year. CORT’s fundamentals are robust with revenue and earnings both projected to grow thi...

2週間前 · Trefis

What IJR's Own History Says About Its Price Today

This popular small-cap fund is trading at a premium to its own history, forcing a hard look at whether the growth inside is enough to justify the price.

2週間前 · Stocktwits

These 2 Biotech Stocks Hit New 52-Week Highs Today – And CORT Clocked Its Best Day In Nearly 16 Months

Corcept Therapeutics and Anika Therapeutics received Wall Street support after reporting strong second-quarter results and sharply raising their full-year 2026 outlook.

2ページ中1ページ

Corcept Therapeutics (CORT)